Ypsomed Holding AG
YPSN
株式のランク
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
株価
$469.39
時価総額
$6.17B
変化（1日）
1.63%
変化（1年）
18.98%
国
CH
取引 Ypsomed Holding AG (YPSN)
カテゴリー
Healthcare
Ypsomed Holding AG（YPSN）のP/E比率
2026 時点のP/E比率 TTM 0
Ypsomed Holding AG の最新の財務報告および株価によると、現在の P/E (TTM) は 0 です。2026 年末時点での P/E は 0 でした。
Ypsomed Holding AG の P/E 比率の履歴（2002 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2025 | 52.96 | -14.36% |
| 2024 | 61.85 | 22.83% |
| 2023 | 50.35 | -43.56% |
| 2022 | 89.21 | -74.08% |
| 2021 | 344.22 | 156.38% |
| 2020 | 134.26 | 397.39% |
| 2019 | 26.99 | -23.24% |
| 2018 | 35.17 | -32.11% |
| 2017 | 51.80 | 7.19% |
| 2016 | 48.33 | -18.25% |
| 2015 | 59.12 | -17.99% |
| 2014 | 72.08 | -82.56% |
| 2013 | 413.31 | 406.81% |
| 2012 | 81.55 | -40.99% |
| 2011 | 138.21 | 59.97% |
| 2010 | 86.40 | 183.61% |
| 2009 | 30.46 | -15.15% |
| 2008 | 35.90 | -90.80% |
| 2007 | 390.29 | 859.06% |
| 2006 | 40.70 | 23.88% |
| 2005 | 32.85 | 103.69% |
| 2004 | 16.13 | 3.77% |
| 2003 | 15.54 | -89.36% |
| 2002 | 146.00 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 26.50 | - |
IE
|
|
| 81.39 | - |
CN
|
|
| - | - |
CH
|
|
| 22.17 | - |
CN
|
|
| 19.80 | - |
KR
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。